Drag a card by its title · ⚙ to size, swap or remove

The company

Jazz Pharmaceuticals plc -

JAZZ · Nasdaq

Health CarePharmaceuticalsNot moving yet

JAZZ stood above a rising 150-day average in 49 of the last 52 weekly readings, and has been out of that trend for the last 2 weeks. It is 8.0% below that average now. Pharmaceuticals: 31% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Not moving yet
Weeks in an uptrend: out for 2
Industry in uptrend: 31% -7 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $115.8M
Officials’ trades on record: 8
Institutions holding: 602 (+64)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 49 of 52 weeks.

17 Apr – 16 Oct

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

8 disclosed lines: House 7, Senate 0, executive 1; 6 people.

Who	Did	Amount	Traded
Bryan Bedford Executive branch: Office of Government EthicsDepartment of Transportation	sold	$50k–$100k	10 Sep 2025filed 19 Dec 2025
Daniel S. Goldman House: U.S. House ClerkNY10	sold	$15k–$50k	12 Jul 2023filed 13 Aug 2023
Daniel S. Goldman House: U.S. House ClerkNY10	bought	$15k–$50k	6 Mar 2023filed 17 Apr 2023
Daniel S. Goldman House: U.S. House ClerkNY10	sold	$1k–$15k	31 Jan 2023filed 24 Feb 2023
Thomas R. Suozzi House: U.S. House ClerkNY03	bought	$1k–$15k	19 Oct 2021filed 5 Nov 2021
Bill Flores House: U.S. House ClerkTX17	bought	$15k–$50k	15 Jul 2019filed 12 Aug 2019
Carlos Curbelo House: U.S. House ClerkFL26	bought	$1k–$15k	28 Aug 2018filed 25 Sep 2018
Thomas MacArthur House: U.S. House ClerkNJ03	sold	$1k–$15k	27 May 2015filed 7 Jun 2015

Insiders

Buy orders, 12 months0

Sale orders, 12 months32

Buyers · sellers0 · 11

Who	Did	Shares	Traded
Renee D. GalaPresident & CEO	sold	2,000at $236.40	6 Oct 2026filed 7 Oct 2026
Bruce C. CozaddDirector	sold	6,000at $230.33	1 Oct 2026filed 5 Oct 2026
Neena M. PatilEVP & Chief Legal Officer	sold	1,200at $240.94	10 Sep 2026filed 14 Sep 2026
Renee D. GalaPresident & CEO	sold	2,000at $243.03	8 Sep 2026filed 10 Sep 2026
Bruce C. CozaddDirector	sold	6,000at $250.13	1 Sep 2026filed 2 Sep 2026
Robert IannoneEVP, Global Head of R&D & CMO	sold	18,187at $247.86	27 Aug 2026filed 31 Aug 2026
Robert IannoneEVP, Global Head of R&D & CMO	sold	11,423at $248.67	27 Aug 2026filed 31 Aug 2026
Robert IannoneEVP, Global Head of R&D & CMO	sold	18,113at $250.02	27 Aug 2026filed 31 Aug 2026
Robert IannoneEVP, Global Head of R&D & CMO	sold	19,639at $250.60	27 Aug 2026filed 31 Aug 2026
Robert IannoneEVP, Global Head of R&D & CMO	sold	9,259at $251.95	27 Aug 2026filed 31 Aug 2026
Robert IannoneEVP, Global Head of R&D & CMO	sold	300at $252.76	27 Aug 2026filed 31 Aug 2026
Bruce C. CozaddDirector	sold	6,000at $252.98	3 Aug 2026filed 5 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders602+64 on the quarter

New · exited129 · 65

Reported value$14.7B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
BlackRock, Inc.added · filed 7 Aug 2026	5,968,603$1.4B	+376,903+6.7%
FMR LLCadded · filed 13 Aug 2026	4,609,326$1.1B	+2,333,564+102.5%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026	3,036,213$731.6M	+52,971+1.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	2,729,650$657.8M	+81,317+3.1%
Capital World Investorsadded · filed 12 Aug 2026	2,697,610$650.0M	+24,234+0.9%
FRANKLIN RESOURCES INCadded · filed 13 Aug 2026	2,040,250$491.6M	+81,310+4.2%
STATE STREET CORPadded · filed 7 Aug 2026	1,999,816$481.9M	+108,170+5.7%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026	1,713,592$412.9M	-181,623−9.6%
FULLER & THALER ASSET MANAGEMENT, INC.reduced · filed 12 Aug 2026	1,638,544$394.8M	-37,598−2.2%
Bank of New York Mellon Corpreduced · filed 6 Aug 2026	1,578,013$380.3M	-101,358−6.0%